Journal of Vaccine Research 2024, Vol.14, No.5, 243-254 http://medscipublisher.com/index.php/jvr 253 Liu J., Miao L., Sui J., Hao Y., and Huang G., 2019, Nanoparticle cancer vaccines: design considerations and recent advances, Asian Journal of Pharmaceutical Sciences, 15: 576-590. https://doi.org/10.1016/j.ajps.2019.10.006 Li Y., Fang H., Tao Z., Wang Y., Qi T., Li B., and Jiao H., 2022, Lipid-mRNA nanoparticles landscape for cancer therapy, Frontiers in Bioengineering and Biotechnology, 10: 1053197. https://doi.org/10.3389/fbioe.2022.1053197 Lozano D., Larraga V., Vallet‐Regí M., and Manzano M., 2023, An overview of the use of nanoparticles in vaccine development, Nanomaterials, 13(12): 1828 https://doi.org/10.3390/nano13121828 Lung P., Yang J., and Li Q., 2020, Nanoparticle formulated vaccines: opportunities and challenges, Nanoscale, 12(10): 5315-5332. https://doi.org/10.1039/c9nr08958f Lu Y., Wu F., Duan W., Mu X., Fang S., Lu N., Zhou X., and Kong W., 2020, Engineering a "PEG-g-PEI/DNA nanoparticle-in-PLGA microsphere" hybrid controlled release system to enhance immunogenicity of DNA vaccine, Materials Science and Engineering: C, 106: 110294. https://doi.org/10.1016/j.msec.2019.110294 Meng L., Teng Z., Yang S., Wang N., Guan Y., Chen X., and Liu Y., 2023, Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy, Nanoscale, 15(2): 467-479. https://doi.org/10.1039/d2nr07071e Nam J., Son S., Park K., and Moon J., 2021, Modularly programmable nanoparticle vaccine based on polyethyleneimine for personalized cancer immunotherapy, Advanced Science, 8(6): 2002577. https://doi.org/10.1002/advs.202002577 Namiot E., Sokolov A., Chubarev V., Tarasov V., and Schiöth H., 2023, Nanoparticles in clinical trials: analysis of clinical trials, FDA approvals and use for COVID-19 vaccines, International Journal of Molecular Sciences, 24(1): 787. https://doi.org/10.3390/ijms24010787 Nguyen B., and Tolia N., 2021, Protein-based antigen presentation platforms for nanoparticle vaccines, NPJ Vaccines, 6: 70. https://doi.org/10.1038/s41541-021-00330-7 Pati R., Shevtsov M., and Sonawane A., 2018, Nanoparticle vaccines against infectious diseases, Frontiers in Immunology, 9: 2224. https://doi.org/10.3389/fimmu.2018.02224 Pilkington E., Suys E., Trevaskis N., Wheatley A., Zukancic D., Algarni A., Al-Wassiti H., Davis T., Pouton C., Kent S., and Truong N., 2021, From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases, Acta Biomaterialia, 131: 16-40. https://doi.org/10.1016/j.actbio.2021.06.023 Polack F., Thomas S., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J., Marc G., Moreira E., Zerbini C., Bailey R., Swanson K., Roychoudhury S., Koury K., Li P., Kalina W., Cooper D., Frenck R., Hammitt L., Türeci Ö., Nell H., Schaefer A., Ünal S., Tresnan D., Mather S., Dormitzer P., Şahin U., Jansen K., and Gruber W., 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, The New England Journal of Medicine, 383(27): 2603-2615. https://doi.org/10.1056/NEJMoa2034577 Reddy S., Vlies A., Simeoni E., Angeli V., Randolph G., O'Neil C., Lee L., Swartz M., and Hubbell J., 2007, Exploiting lymphatic transport and complement activation in nanoparticle vaccines, Nature Biotechnology, 25: 1159-1164. https://doi.org/10.1038/nbt1332 Salem A., 2015, Nanoparticles in vaccine delivery, The AAPS Journal, 17(2): 289-291. https://doi.org/10.1208/s12248-015-9720-1 Sarangi M., Padhi S., Rath G., Nanda S., and Yi D., 2022, Success of nano-vaccines against COVID-19: a transformation in nanomedicine, Expert Review of Vaccines, 21(12): 1739-1761. https://doi.org/10.1080/14760584.2022.2148659 Silva C., Camps M., Li T., Chan A., Ossendorp F., and Cruz L., 2019, Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines, Biomaterials, 220: 119417. https://doi.org/10.1016/j.biomaterials.2019.119417 Silva J., Videira M., Gaspar R., Préat V., and Florindo H., 2013, Immune system targeting by biodegradable nanoparticles for cancer vaccines, Journal of Controlled Release, 168(2): 179-199. https://doi.org/10.1016/j.jconrel.2013.03.010 Shou C.J., and Cai X.P., 2024, Analysis of animal vaccine classification and current status, Journal of Vaccine Research, 14(1): 10-16. https://doi.org/10.5376/jvr.2024.14.0002 Smith J., Morton L., and Ulery B., 2015, Nanoparticles as synthetic vaccines, Current Opinion in Biotechnology, 34: 217-224. https://doi.org/10.1016/j.copbio.2015.03.014 Tenchov R., Bird R., Curtze A., and Zhou Q., 2021, Lipid nanoparticles=from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement, ACS Nano, 15(11): 16982-17015. https://doi.org/10.1021/acsnano.1c04996 Thi T., Suys E., Lee J., Nguyen D., Park K., and Truong N., 2021, Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines, Vaccines, 9(4): 359. https://doi.org/10.3390/vaccines9040359
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==